Sale!

DIAPH1 Gene Deafness Autosomal Dominant Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DIAPH1 gene, associated with Deafness Autosomal Dominant Type 1, plays a critical role in auditory function. Mutations in this gene can lead to a form of non-syndromic hearing loss, where the impairment of hearing is the only symptom presented, without affecting other systems of the body. The condition is inherited in an autosomal dominant pattern, meaning only one copy of the altered gene in each cell is sufficient to cause the disorder.

To identify mutations in the DIAPH1 gene, a specific genetic test is available at DNA Labs UAE. This test is a crucial tool for diagnosing individuals with hearing loss that may be attributed to this genetic variant. It involves analyzing the DNA to detect mutations in the DIAPH1 gene that are known to cause autosomal dominant deafness.

The cost of the DIAPH1 Gene Deafness Autosomal Dominant Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This test is not only vital for the accurate diagnosis of the condition but also plays a significant role in family planning and genetic counseling for families affected by this type of hearing loss. By identifying carriers of the gene mutation, families can make informed decisions about future pregnancies, and individuals can receive tailored advice and support for managing their condition.

Description

DIAPH1 Gene Deafness autosomal dominant type 1 Genetic Test

Test Name: DIAPH1 Gene Deafness autosomal dominant type 1 Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA2

Test Details: The DIAPH1 gene is associated with a condition called Deafness, autosomal dominant type 1. This condition is characterized by progressive hearing loss that begins in childhood or adolescence. It is inherited in an autosomal dominant manner, which means that an affected individual has a 50% chance of passing the condition on to their children. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the case of DIAPH1 gene deafness, an NGS genetic test would involve sequencing the DIAPH1 gene to identify any variations or mutations that may be responsible for the condition. NGS genetic testing can provide valuable information about an individual’s genetic makeup and help diagnose genetic conditions. It can also be used for carrier testing, prenatal testing, and predicting the risk of developing certain genetic disorders. If you suspect that you or someone you know may have DIAPH1 gene deafness, it is recommended to consult with a healthcare professional or a genetic counselor who can provide further information and guidance on genetic testing options.

Test Name	DIAPH1 Gene Deafness autosomal dominant type 1 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Ear Nose Throat Disorders
Doctor	ENT Doctor
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA2
Test Details	The DIAPH1 gene is associated with a condition called Deafness, autosomal dominant type 1. This condition is characterized by progressive hearing loss that begins in childhood or adolescence. It is inherited in an autosomal dominant manner, which means that an affected individual has a 50% chance of passing the condition on to their children. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the case of DIAPH1 gene deafness, an NGS genetic test would involve sequencing the DIAPH1 gene to identify any variations or mutations that may be responsible for the condition. NGS genetic testing can provide valuable information about an individual’s genetic makeup and help diagnose genetic conditions. It can also be used for carrier testing, prenatal testing, and predicting the risk of developing certain genetic disorders. If you suspect that you or someone you know may have DIAPH1 gene deafness, it is recommended to consult with a healthcare professional or a genetic counselor who can provide further information and guidance on genetic testing options.